MX9707009A - Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women. - Google Patents

Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women.

Info

Publication number
MX9707009A
MX9707009A MX9707009A MX9707009A MX9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A
Authority
MX
Mexico
Prior art keywords
perimenopausal
injectable
month
once
useful
Prior art date
Application number
MX9707009A
Other languages
Spanish (es)
Inventor
Ursula Lachnit-Fixson
Semiramis Aydinlik
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MX9707009A publication Critical patent/MX9707009A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

A once-a-month-injectable that contains an oestrogen and a gestagen component as active substances is used to prepare a contraceptive medicament useful at the same time in the hormone replacement therapy for perimenopausal and premenopausal women. A reliable contraceptive effect with a "natural" oestrogen (without ethinyl oestradiol) is achieved with this medicament, as well as an effective therapy of the first oestrogen deficiency symptoms and the prevention of osteoporosis.
MX9707009A 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women. MX9707009A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (en) 1995-03-16 1995-03-16 One-month injection as a depot contraceptive and for hormone replacement therapy for peri- and premenopausal women
PCT/EP1996/001201 WO1996028165A1 (en) 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women

Publications (1)

Publication Number Publication Date
MX9707009A true MX9707009A (en) 1997-11-29

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707009A MX9707009A (en) 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women.

Country Status (17)

Country Link
EP (1) EP0814811A1 (en)
JP (1) JPH11501649A (en)
KR (1) KR19980703058A (en)
AR (1) AR002283A1 (en)
AU (1) AU713258B2 (en)
CA (1) CA2215382A1 (en)
CZ (1) CZ289697A3 (en)
DE (1) DE19510861A1 (en)
HU (1) HUP9801691A3 (en)
IL (1) IL117516A (en)
MX (1) MX9707009A (en)
NO (1) NO974255L (en)
NZ (1) NZ304027A (en)
PL (1) PL322202A1 (en)
SK (1) SK123997A3 (en)
WO (1) WO1996028165A1 (en)
ZA (1) ZA962177B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
IL117516A0 (en) 1996-07-23
HUP9801691A2 (en) 1998-11-30
AU5110896A (en) 1996-10-02
EP0814811A1 (en) 1998-01-07
NZ304027A (en) 2000-05-26
NO974255D0 (en) 1997-09-15
ZA962177B (en) 1996-07-29
CA2215382A1 (en) 1996-09-19
CZ289697A3 (en) 1997-12-17
HUP9801691A3 (en) 1999-03-01
SK123997A3 (en) 1998-02-04
PL322202A1 (en) 1998-01-19
AU713258B2 (en) 1999-11-25
JPH11501649A (en) 1999-02-09
NO974255L (en) 1997-11-14
IL117516A (en) 2000-07-26
KR19980703058A (en) 1998-09-05
DE19510861A1 (en) 1996-09-19
WO1996028165A1 (en) 1996-09-19
AR002283A1 (en) 1998-03-11

Similar Documents

Publication Publication Date Title
DE69710896D1 (en) Progestogen-anti-progestogen therapien
EP0402950A3 (en) Treatment of postmenopausal disorders
PL327182A1 (en) Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor
IL122109A0 (en) A two-stage pharmaceutical preparation for hormonal contraception and a kit containing the same
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
UA41401C2 (en) Pharmaceutical combined contraceptive agent
UA48973C2 (en) Transdermal patch containing 17-deacetyl norgestimate for preventing ovulation
EP1319404A3 (en) Composition for treating and/or prophylaxis of tumors of the breast
GR1003011B (en) Novel formulation
BG104451A (en) Antiestrogen and progestin-containing peroral contraceptives
BG101349A (en) Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
LU90341I2 (en) 75 Ug desogestrel in the absence of ethinyl estradiol (cerazette)
WO1994002103A3 (en) Ovulation inhibitor for hormonal contraception
MX9707009A (en) Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women.
UA41351C2 (en) Contraception method and tablets for contraception
HUP9903097A2 (en) Medicament containing progestogen-anti-progestogen

Legal Events

Date Code Title Description
FG Grant or registration
GD Licence granted
HC Change of company name or juridical status

Owner name: PFIZER IRELAND PHARMACEUTICALS

MM Annulment or lapse due to non-payment of fees